EN DE
STOCK COMPARISON

Dis-Chem Pharmacies vs Jd Health International Inc: Fair Value & Quality

Both stocks run through our valuation models. Here is how Dis-Chem Pharmacies (DCP) and Jd Health International Inc (6618) compare, as of Aug 11, 2026.

As of Aug 11, 2026, Fair Value Calculator sees Jd Health International Inc as the less overvalued of the two: Dis-Chem Pharmacies trades at ZAR 32.20 versus a fair value of ZAR 24.01 (-25%), while Jd Health International Inc trades at HK$40.08 versus HK$33.28 (-17%).
Dis-Chem Pharmacies
DCP.JSE · ZAR · Consumer Staples
-25%
upside to fair value
overvalued
PriceZAR 32.20
Fair ValueZAR 24.01
Quality55/100
Jd Health International Inc
6618.HK · HKD · Health Care
-17%
upside to fair value
overvalued
PriceHK$40.08
Fair ValueHK$33.28
Quality72/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Dis-Chem PharmaciesJd Health International Inc
Valuation
28.2×P/E (TTM)17.6×
0.64×P/S (TTM)1.48×
4.88×P/B1.81×
12.5×EV/EBITDA19.4×
PEG1.26×
0.0%Dividend yield
Profitability
2%Net margin7%
3%Operating margin4%
19%Return on equity9%
6%Return on assets3%
Growth
10%Revenue growth (YoY)28%
9.4%Avg. growth/yr (3Y)16.3%
10.3%Avg. growth/yr (5Y)30.5%
Balance & size
0.27×Debt / equity
$2BMarket cap$14B
healthyGrowth qualityhealthy

Jd Health International Inc leads: 4 to 7 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Dis-Chem Pharmaciesof which business quality 55 · market factors 43 Jd Health International Incof which business quality 74 · market factors 22
ProfitabilityMargins and returns on capital today
59
47
Quality GrowthAre margins and returns improving?
41
80
CashflowEarnings quality: real cash, not paper profit
46
76
Fin. StrengthBalance sheet, leverage, solvency risk
45
100
InvestmentDisciplined investing over empire-building
60
66
Low VolatilityCalm price path (market factor)
88
42
MomentumPrice trend over the last 3–12 months (market factor)
28
12
52W MomentumDistance to the 52-week high (market factor)
17
18
Net IssuanceBuybacks instead of dilution
82
73

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Dis-Chem Pharmacies

DCF ModelsZAR 30.14
Earnings-BasedZAR 15.96
Dividend DiscountZAR 10.78
MultiplesZAR 26.56
Asset-BasedZAR 4.42
Growth DCFZAR 30.92
Economic ProfitZAR 17.50
Growth EarningsZAR 20.15

19 of 26 models see the stock below the current price.

Jd Health International Inc

DCF ModelsHK$70.32
Earnings-BasedHK$51.28
MultiplesHK$28.65
Asset-BasedHK$12.62
Growth DCFHK$77.68
Economic ProfitHK$20.89
Growth EarningsHK$70.00

10 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Dis-Chem Pharmacies
Bear ZAR 18.01Fair Value ZAR 24.01Bull ZAR 30.01
ZAR 32.20 = current price (white tick)
Jd Health International Inc
Bear HK$25.37Fair Value HK$33.28Bull HK$41.60
HK$40.08 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Dis-Chem Pharmacies · Consumer Staples

Quality score55 · below median
Fair value upside-25% · below median

Jd Health International Inc · Health Care

Quality score72 · Top 25%
Fair value upside-17% · above median

Bottom line

As of Aug 11, 2026, Fair Value Calculator sees Jd Health International Inc as the less overvalued of the two: Dis-Chem Pharmacies trades at ZAR 32.20 versus a fair value of ZAR 24.01 (-25%), while Jd Health International Inc trades at HK$40.08 versus HK$33.28 (-17%).

Jd Health International Inc has the higher quality score (72/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.